Eli Lilly And Co. (LLY) News Headlines

▮ More

Date

Headline

4/16/2021 6:50:40 AM Eli Lilly Requests FDA Revoke EUA For Bamlanivimab 700 Mg Alone - Quick Facts

4/16/2021 6:31:50 AM Eli Lilly Requests FDA Revoke Emergency Use Authorization For Bamlanivimab 700 Mg Alone

4/13/2021 6:43:44 AM Eli Lilly Appoints Diogo Rau To Head Information Technology And Digital Capabilities

4/13/2021 6:32:41 AM Lilly Names Diogo Rau SVP And Chief Information And Digital Officer Succeeding Aarti Shah

4/12/2021 9:51:18 PM Lilly : Phase 3 Study Shows Sintilimab Improves OS For Squamous Non-small Cell Lung Cancer Patients

4/12/2021 9:01:27 PM Innovent And Lilly Release Phase 3 Results Of TYVYT As Second-Line Treatment For Squamous Non-Small Cell Lung Cancer

4/12/2021 6:58:46 AM Eli Lilly, U.S. Government Amend Purchase Agreements For Neutralizing Antibody Therapies

4/12/2021 6:48:11 AM Eli Lilly Announces Changes To Purchase Agreements With US Government For Neutralizing Antibody Therapies

4/8/2021 7:41:24 AM Eli Lilly Says Late-stage Study Of Baricitinib In Hospitalized Covid Patients Didn't Meet Main Goal

4/8/2021 6:47:35 AM Lilly, Incyte: Phase 3 COV-BARRIER Study Of Baricitinib Fails To Meet Statistical Significance On Primary Endpoint

3/29/2021 8:58:45 AM Lilly, Vir And GSK Announce Positive Data From Phase 2 BLAZE-4 Trial On COVID-19

3/29/2021 8:31:48 AM Lilly, Vir Biotechnology, GSK Announce Positive Topline Data From Phase 2 BLAZE-4 Trial In Low-Risk Adults With COVID-1

3/23/2021 1:31:22 AM AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA Approval, AdComm To Review Osteoarthritis Drug

3/17/2021 7:02:41 AM Lilly Reports Patient-Reported Outcomes From Phase 3 MonarchE Trial For Verzenio

3/17/2021 6:47:11 AM Lilly Presents Patient-Reported Outcomes From Positive Phase 3 MonarchE Trial For Verzenio

3/17/2021 2:18:58 AM CELC Inks Breast Cancer Trial Collaboration, CANF Soars On Deal With Ewopharma, MRUS On Watch

3/16/2021 7:47:55 AM Eli Lilly Says Mirikizumab Meets Primary Endpoint In Patients With UC

3/16/2021 6:49:48 AM Lilly Says Mirikizumab Meets Primary Endpoint In LUCENT-1 Study In Adults With Ulcerative Colitis

3/10/2021 7:27:12 AM Lilly' Bamlanivimab & Etesevimab Reduce Hospitalizations & Death In Phase 3 Trial For Early COVID-19

3/10/2021 7:06:22 AM Lilly Says New BLAZE-1 Phase 3 Study Date Reduced Hospitalizations And Death By 87% For Early COVID-19